Sex Differences in the Development of Malignancies among End-Stage Renal Disease Patients: A Nationwide Population-Based Follow-Up Study in Taiwan

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Chung, Chi Jung ^a   Huang, Chao Yuan ^b   Tsai, Hung Bin ^b   Muo, Chih Hsin ^a   Chung, Mu Chi ^c   Chang, Chao Hsiang ^a,d   Huang, Chiu Ching ^a,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PERITONEAL DIALYSIS; POPULATION RESEARCH; SEX DIFFERENCE; TAIWAN; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASMS; PERITONEAL DIALYSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL DIALYSIS; RISK; RISK FACTORS; SEX CHARACTERISTICS; SEX FACTORS; TAIWAN;

EID: 84866040705     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044675     Document Type: Article

References (34)

1. Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, et al. (2004) Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 44: 198-206.
2. Parfrey PS, Foley RN, Rigatto C, (1999) Risk issues in renal transplantation: cardiac aspects. Transplant Proc 31: 291-293.
3. Parfrey PS, Foley RN, (1999) The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10: 1606-1615.
4. Weng PH, Hung KY, Huang HL, Chen JH, Sung PK, et al. (2011) Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 6: 1121-1128.
5. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, et al. (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354: 93-99.
6. Lee JE, Han SH, Cho BC, Park JT, Yoo TH, et al. (2009) Cancer in patients on chronic dialysis in Korea. J Korean Med Sci 24: S95-S101.
7. Chen KS, Lai MK, Huang CC, Chu SH, Leu ML, (1995) Urologic cancers in uremic patients. Am J Kidney Dis 25: 694-700.
8. Boon NA, Michael J, (1984) Multiple neoplasia in a patient on dialysis presenting with haematuria. Br J Urol 56: 96-97.
9. Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, et al. (2009) The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 24: 3225-3231.
10. Birkeland SA, Lokkegaard H, Storm HH, (2000) Cancer risk in patients on dialysis and after renal transplantation. Lancet 355: 1886-1887.
11. Sassa N, Hattori R, Tsuzuki T, Watarai Y, Fukatsu A, et al. (2011) Renal cell carcinomas in haemodialysis patients: does haemodialysis duration influence pathological cell types and prognosis? Nephrol Dial Transplant 26: 1677-1682.
12. Nouh MA, Kuroda N, Yamashita M, Hayashida Y, Yano T, et al. (2010) Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis. BJU Int 105: 620-627.
13. Suthanthiran M, Strom TB, (1994) Renal transplantation. N Engl J Med 331: 365-376.
14. Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, et al. (2006) Cancer incidence before and after kidney transplantation. JAMA 296: 2823-2831.
15. Hurst FP, Jindal RM, Graham LJ, Falta EM, Elster EA, et al. (2010) Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experience. Transplantation 90: 898-904.
16. Silbiger SR, Neugarten J, (1995) The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25: 515-533.
17. Hung PH, Shen CH, Tsai HB, Hsiao CY, Chiang PC, et al. (2011) Gender effect on renal outcome in patients with urothelial carcinoma. World J Urol 29: 511-516.
18. Lu JF, Hsiao WC, (2003) Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff 22: 77-88.
19. Vamvakas S, Bahner U, Heidland A, (1998) Cancer in end-stage renal disease: potential factors involved-editorial-. Am J Nephrol 18: 89-95.
20. Fischereder M, (2008) Cancer in patients on dialysis and after renal transplantation. Nephrol Dial Transplant 23: 2457-2460.
21. Chen CH, Shun CT, Huang KH, Huang CY, Yu HJ, et al. (2008) Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease. Urology 71: 1155-1160.
22. Liang JA, Sun LM, Yeh JJ, Sung FC, Chang SN, et al. (2011) The Association Between Malignancy and End-stage Renal Disease in Taiwan. Jpn J Clin Oncol 41: 752-757.
23. Farivar-Mohseni H, Perlmutter AE, Wilson S, Shingleton WB, Bigler SA, et al. (2006) Renal cell carcinoma and end stage renal disease. J Urol 175: 2018-2020.
24. Li WH, Chen YJ, Tseng WC, Lin MW, Chen TJ, et al. (2012) Malignancies after renal transplantation in Taiwan: a nationwide population-based study. Nephrol Dial Transplant 27: 833-839.
25. Hurst FP, Jindal RM, Fletcher JJ, Dharnidharka V, Gorman G, et al. (2011) Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients. Urology 77: 1271-1276.
26. Kummer S, von GG, Kemper MJ, Oh J, (2012) The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease. Pediatr Nephrol 27: 1213-1219.
27. Yang HY, Wang JD, Lo TC, Chen PC, (2009) Increased mortality risk for cancers of the kidney and other urinary organs among Chinese herbalists. J Epidemiol 19: 17-23.
28. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, et al. (2008) All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 371: 2173-2182.
29. Cosyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersele de SC, (1999) Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 33: 1011-1017.
30. Cosyns JP, Dehoux JP, Guiot Y, Goebbels RM, Robert A, et al. (2001) Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int 59: 2164-2173.
31. Chang CH, Fang YW, Chen HS, (2009) End-stage renal disease in both husband and wife in Taiwan. Clin Nephrol 72: 298-302.
32. Lai MN, Lai JN, Chen PC, Tseng WL, Chen YY, et al. (2009) Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid. Nephrology 14: 227-234.
33. Orskov B, Sorensen VR, Feldt-Rasmussen B, Strandgaard S, (2012) Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Nephrol Dial Transplant 27: 1607-1613.
34. Lindsay RM, Suri RS, Moist LM, Garg AX, Cuerden M, et al. (2011) International quotidian dialysis registry: Annual report 2010. Hemodial Int 15: 15-22.